Medtronic Plc’s shares may fluctuate by as much as 4% on Sept. 1, when the company is scheduled to release its quarterly results before the market opens, according to options data compiled by Bloomberg.
The expected volatility reflects a two-year range in which implied stock movements for Medtronic’s earnings announcements have fluctuated between 3.0% and 4.1%. Over the prior eight quarters, the medical device manufacturer has exceeded implied variations in five instances, though the magnitude of actual moves has varied significantly.
In the most recent earnings release on June 3, Medtronic’s stock moved just 0.5%, below the 4.1% implied variation at the time. By contrast, the February 2026 reporting period saw shares decline 5.2%, surpassing the 3.6% implied move. The largest swing occurred in November 2025, when the stock rose 8.8%, more than double the 3.6% implied variation. The smallest move was in May 2025, with a 0.8% drop against a 3.0% implied variation.
Medtronic, listed on the New York Stock Exchange under the ticker MDT, is a medical device manufacturer with a history of earnings-driven volatility. The company’s next report is due before the market opens on Sept. 1.
